Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 4, 2005, Pages 283-288

  Ay, Emine ^a   Kavak, Zehra Nese ^a   Elter, Koray ^a,b   Gokaslan, Husnu ^a   Pekin, Tanju ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Activin A; Alpha fetoprotein; Doppler; hCG; Inhibin A; Pre eclampsia; Screening; Uterine artery

Indexed keywords

ACTIVIN A; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

ADULT; ARTERY RESISTANCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY;

ACTIVINS; ADULT; ALPHA-FETOPROTEINS; ARTERIES; BLOOD FLOW VELOCITY; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; INHIBIN-BETA SUBUNITS; INHIBINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERUS; VASCULAR RESISTANCE;

EID: 23744442730     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00412.x     Document Type: Article

References (36)

1. Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-1265.
2. Hsu CD, Chan DW, Iriye B, Johnson TR, Hong SF, Repke JT. Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol. 1994; 170: 1135-1138.
3. Walters BN, Lao T, Smith V, De Swiet M. Alpha-Fetoprotein elevation and proteinuric pre-eclampsia. Br J Obstet Gynaecol. 1985; 92: 341-344.
4. Fraser RF III, McAsey ME, Coney P. Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin. Am J Reprod Immunol. 1998; 40: 37-42.
5. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 1999; 180: 1131-1137.
6. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997; 349: 1285-1288.
7. Leung TN, Chung TK, Madsen G et al. Analysis of midtrimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia. Hum Reprod 2000; 15: 1813-1818.
8. Onderoglu LS, Kabukcu A. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynaecol. Obstet 1997; 56: 245-249.
9. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999; 19: 122-127.
10. Pouta AM, Hartikainen AL, Vuolteenaho OJ, Ruokonen AO, Laatikainen TJ. Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia. Obstet Gynecol. 1998; 91: 940-944.
11. Muttukrishna S, North RA, Morris J et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000; 15: 1640-1645.
12. Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol. 2000; 182: 589-594.
13. Wald NJ, Morris JK. Multiple marker second trimester serum screening for pre-eclampsia. J Med Screen 2001; 8: 65-68.
14. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994; 101: 669-674.
15. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol. 2000; 96: 559-564.
16. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol. 1986; 68: 649-653.
17. Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol. 2001; 17: 477-484.
18. Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2003; 21: 165-169.
19. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183: S1-S22.
20. Lee IS, Chung DY, Cole LA, Copel JA, Isozaki T, Hsu CD. Elevated serum nicked and urinary beta-core fragment hCG in preeclamptic pregnancies. Obstet Gynecol. 1997; 90: 889-892.
21. Muller F, Savey L, Le Fiblec B et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol. 1996; 175: 37-40.
22. Bahado-Singh RO, Oz U, Isozaki T et al. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia. Am J Obstet Gynecol. 1998; 179: 738-741.
23. Ashour AM, Lieberman ES, Haug LE, Repke JT. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol. 1997; 176: 438-442.
24. Vaillant P, David E, Constant I et al. Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron 1996; 72: 557-563.
25. Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol. Scand. 1998; 77: 381-384.
26. Morssink LP, Heringa MP, Beekhuis JR, De Wolf BT, Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol. 1997; 89: 666-670.
27. Heinonen S, Ryynanen M, Kirkinen P, Saarikoski S. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. Am. J. Perinatol. 1996; 13 437-441.
28. Grobman WA, Wang EY. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol. 2000; 96: 390-394.
29. Lambert-Messerlian GM, Silver HM, Petraglia F et al. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gvnecol Invest 2000; 7: 170-174.
30. Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. Bjog 2003; 110: 46-52.
31. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol. 1998; 105: 1101-1103.
32. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol. 1999; 181: 131-136.
33. Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10-14 weeks of gestation is associated with pre-eclampsia. Bjog 2000; 107: 795-797.
34. Brazerol WF, Grover S, Donnenfeld AE. Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol. 1994; 171: 1030-1035.
35. Wenstrom KD, Owen J, Davis RO, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol. 1996; 87: 213-216.
36. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004; 104: 1367-1391.